These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21796469)

  • 1. Determining outcomes, adverse events, and predictors of success after sacral neuromodulation for lower urinary disorders in women.
    Yazdany T; Bhatia N; Nguyen J
    Int Urogynecol J; 2011 Dec; 22(12):1549-54. PubMed ID: 21796469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience.
    Groen LA; Hoebeke P; Loret N; Van Praet C; Van Laecke E; Ann R; Vande Walle J; Everaert K
    J Urol; 2012 Oct; 188(4):1313-7. PubMed ID: 22902022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation.
    Siegel S; Noblett K; Mangel J; Bennett J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Zylstra S; Kan F; Berg KC
    J Urol; 2018 Jan; 199(1):229-236. PubMed ID: 28709886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific Changes in Brain Activity during Urgency in Women with Overactive Bladder after Successful Sacral Neuromodulation: A Functional Magnetic Resonance Imaging Study.
    Weissbart SJ; Bhavsar R; Rao H; Wein AJ; Detre JA; Arya LA; Smith AL
    J Urol; 2018 Aug; 200(2):382-388. PubMed ID: 29630979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
    Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
    Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacral Nerve Stimulation in Parkinson's Disease Patients With Overactive Bladder Symptoms.
    Greenberg DR; Sohlberg EM; Zhang CA; Santini VE; Comiter CV; Enemchukwu EA
    Urology; 2020 Oct; 144():99-105. PubMed ID: 32681915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sacral neuromodulation in congenital lumbo-sacral and traumatic spinal cord defects with neurogenic lower urinary tract symptoms: a single-center experience in children and adolescents.
    Sharifiaghdas F
    World J Urol; 2019 Dec; 37(12):2775-2783. PubMed ID: 30864008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial.
    Amundsen CL; Richter HE; Menefee SA; Komesu YM; Arya LA; Gregory WT; Myers DL; Zyczynski HM; Vasavada S; Nolen TL; Wallace D; Meikle SF
    JAMA; 2016 Oct; 316(13):1366-1374. PubMed ID: 27701661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Sacral Nerve Stimulation for Treatment of Refractory Overactive Bladder Among Octogenarians.
    Greenberg DR; Syan R; Young-Lin N; Comiter CV; Enemchukwu E
    Neuromodulation; 2019 Aug; 22(6):738-744. PubMed ID: 31215713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sacral nerve stimulation for neuromodulation of the lower urinary tract.
    Oerlemans DJ; van Kerrebroeck PE
    Neurourol Urodyn; 2008; 27(1):28-33. PubMed ID: 17563110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sacral neuromodulation in urological indications: the Finnish experience.
    Vaarala MH; Tammela TL; Perttilä I; Luukkonen P; Hellström P
    Scand J Urol Nephrol; 2011 Feb; 45(1):46-51. PubMed ID: 20961268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a German high-volume clinic].
    Otto W; Nowrotek A; Burger M; Wieland WF; Rößler W; Denzinger S
    Aktuelle Urol; 2012 May; 43(3):162-6. PubMed ID: 22639025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sacral neuromodulation and cardiac pacemakers.
    Roth TM
    Int Urogynecol J; 2010 Aug; 21(8):1035-7. PubMed ID: 20119858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinence.
    Benson K; McCrery R; Taylor C; Padron O; Blok B; de Wachter S; Pezzella A; Gruenenfelder J; Pakzad M; Perrouin-Verbe MA; Van Kerrebroeck P; Mangel J; Peters K; Kennelly M; Shapiro A; Lee U; Comiter C; Mueller M; Goldman H; Lane F
    Neurourol Urodyn; 2020 Jun; 39(5):1482-1488. PubMed ID: 32339339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
    Hoda MR; Fornara P
    Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urodynamic findings during the filling phase in neurogenic bladder patients with or without vesicoureteral reflux who have undergone sacral neuromodulation.
    Chen G; Liao L; Wang Y; Ying X
    Neurourol Urodyn; 2020 Jun; 39(5):1410-1416. PubMed ID: 32282088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative Predictors of Sacral Neuromodulation Implantation and Treatment Response: Results From the ROSETTA Trial.
    Gill BC; Thomas S; Barden L; Jelovsek JE; Meyer I; Chermansky C; Komesu YM; Menefee S; Myers D; Smith A; Mazloomdoost D; Amundsen CL
    J Urol; 2023 Aug; 210(2):331-340. PubMed ID: 37126070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sacral Nerve Stimulation for Pediatric Lower Urinary Tract Dysfunction: Development of a Standardized Pathway with Objective Urodynamic Outcomes.
    Schober MS; Sulkowski JP; Lu PL; Minneci PC; Deans KJ; Teich S; Alpert SA
    J Urol; 2015 Dec; 194(6):1721-6. PubMed ID: 26141849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing patient preparedness for sacral neuromodulation improves patient reported outcomes despite leaving objective measures of success unchanged.
    Firoozi F; Gill B; Ingber MS; Moore CK; Rackley RR; Goldman HB; Vasavada SP
    J Urol; 2013 Aug; 190(2):594-7. PubMed ID: 23499745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term safety of sacral nerve modulation in medicare beneficiaries.
    Chughtai B; Sedrakyan A; Isaacs A; Lee R; Te A; Kaplan S
    Neurourol Urodyn; 2015 Sep; 34(7):659-63. PubMed ID: 25066920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.